Skip to main content Skip to section navigation Skip to footer

Processa Pharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Partnering
    • Management Team
    • Board of Directors
  • Product Pipeline
    • Overview
    • PCS3117
    • PCS6422
    • PCS11T
    • Publications
  • Our Clinical Trials
    • Overview
    • PCS6422
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • In The News
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact
  • Careers

IR Calendar

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
    • Analyst Coverage
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts

20th Orphan Drugs and Rare Diseases Global Congress 2023 Americas

Nov 16, 2023 2:40 pm EDT

Dr. Young will be available for one-on-one meetings throughout the conference.

For more information about the conference, click below:
https://www.paradigmglobalevents.com/events/21st-orphan-drugs-rare-diseases-global-congress-2023-americas/

  • Email Alerts
  • Contacts
  • RSS News Feed
Twitter LinkedIn
©2025 Processa Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap Manage Cookie Preferences